APP and Alzheimer disease: Moreover, FluVac might also increase the activity of microglial cells, leading to the clearance of β-amyloid proteins, disrupting the Treg-regulated immune system, and exerting immunomodulatory effects on amyloid precursor protein (APP)/presenilin 18,9, thus contribute to some protective effects on AD.